Who
Linda Marban
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Capricor Therapeutics.
In numbers
- Trades disclosed
- 46
- Buys
- 4
- Sells
- 0
- Bought
- $129K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Mar 2015
- Last trade
- 5 Jan 2026
- Last filed
- 7 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 5 Mar 2025filed 5 Mar 2025 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Code J | —12,500 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Code M | $35K25,000 at $1.39 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,962 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,633 at $0.00 | filing |
| 12 May 2023filed 16 May 2023 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,497 at $0.00 | filing |
| 12 May 2023filed 16 May 2023 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Code M | $29K20,749 at $1.39 | filing |
| 3 Jan 2023filed 5 Jan 2023 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 3 Jan 2022filed 4 Jan 2022 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —377,830 at $0.00 | filing |
| 4 Jan 2021filed 6 Jan 2021 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —458,693 at $0.00 | filing |
| 27 Jul 2020filed 29 Jul 2020 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,497 at $0.00 | filing |
| 27 Jul 2020filed 29 Jul 2020 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Code M | $154K41,497 at $3.70 | filing |
News
No headline names them, or the companies they trade most, lately.